Review: taking Zithromax and Remicade together


Summary

Drug interactions are reported among people who take Zithromax and Remicade together. This review analyzes the effectiveness and drug interactions between Zithromax and Remicade. It is created by eHealthMe based on reports of 133 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Zithromax

Zithromax has active ingredients of azithromycin. It is often used in bronchitis. (latest outcomes from Zithromax 22,526 users)

Remicade

Remicade has active ingredients of infliximab. It is often used in rheumatoid arthritis. (latest outcomes from Remicade 97,983 users)

On Aug, 31, 2016

133 people who take Zithromax, Remicade are studied.


Number of reports submitted per year:

Zithromax and Remicade drug interactions.

Drug effectiveness over time:

Zithromax:
  • < 1 month: 25.0% - (1 of 4 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Remicade:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Zithromax:
  • female: 0.0% - (0 of 1 people)
  • male: 33.0% - (1 of 3 people)
Remicade:
  • female: 0.0% - (0 of 1 people)
  • male: 75.0% - (3 of 4 people)

Drug effectiveness by age:

Zithromax:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)
Remicade:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 50.0% - (1 of 2 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • aptyalism
  • auricular swelling
  • blood potassium decreased
  • blood sodium decreased
  • dry mouth
  • electrolyte depletion
  • salivary gland enlargement
  • thirst
  • bronchitis
  • drug ineffective
1 - 6 months:
  • abscess
  • colitis ulcerative
  • congenital anomaly
  • gastrointestinal haemorrhage
  • haemangioma congenital
  • tooth development disorder
  • actinic keratosis
  • arthralgia
  • arthropathy
  • blood pressure increased
6 - 12 months:
  • blood bilirubin increased
  • influenza like illness
  • red blood cell count decreased
  • actinic keratosis
  • blood pressure increased
  • carbon dioxide decreased
  • haematocrit decreased
  • haemoglobin decreased
  • squamous cell carcinoma
1 - 2 years:
  • arthralgia
  • cough
  • drug ineffective
  • epilepsy
  • meningitis cryptococcal
  • nasal congestion
  • pneumonia
  • pulmonary tuberculosis
  • tuberculosis of central nervous system
2 - 5 years:
  • blood creatine phosphokinase increased
  • leukopenia
  • pneumonia legionella
  • thrombocytopenia
  • crohn's disease
  • liver function test abnormal
  • actinic keratosis
  • anaemia
  • aspartate aminotransferase increased
  • barrett's oesophagus
5 - 10 years:
  • cholecystitis chronic
  • drug ineffective
  • fungal infection
  • gallbladder cholesterolosis
  • gallbladder injury
  • hepatosplenic t-cell lymphoma
  • infection
  • lyme disease
  • osteonecrosis
  • osteopenia
not specified:
  • ascites
  • hepatic function abnormal
  • peritoneal tuberculosis
  • pneumonia
  • arthralgia
  • crohn's disease
  • sepsis
  • fall
  • renal failure
  • dyspnoea

Most common drug interactions by gender *:

female:
  • ascites
  • hepatic function abnormal
  • peritoneal tuberculosis
  • pneumonia
  • colitis ulcerative
  • drug ineffective
  • arthralgia
  • lung infiltration
  • skin lesion
  • empyema
male:
  • arthralgia
  • crohn's disease
  • pneumonia
  • sepsis
  • renal failure
  • dyspnoea
  • fall
  • pain
  • tooth abscess
  • dyspepsia

Most common drug interactions by age *:

2-9:
  • crohn's disease
  • gastroenteritis viral
  • pneumonia
  • stevens-johnson syndrome
10-19:
  • colitis ulcerative
  • crohn's disease
  • abscess
  • abscess bacterial
  • gastrointestinal haemorrhage
  • pain
  • pneumonia
  • wound dehiscence
  • acquired oesophageal web
  • actinic keratosis
20-29:
  • clostridial infection
  • colitis
  • disseminated intravascular coagulation
  • drug ineffective
  • eating disorder
  • fungal infection
  • hepatic failure
  • malaise
  • nasopharyngitis
  • urinary tract infection
30-39:
  • histoplasmosis
  • renal failure
  • respiratory failure
  • sepsis
  • splenomegaly
  • hepatic steatosis
  • barrett's oesophagus
  • biopsy lung abnormal
  • cholecystitis chronic
  • cholelithiasis
40-49:
  • adverse event
  • coagulopathy
  • ear disorder
  • epistaxis
  • erythema
  • haematochezia
  • lung infiltration
  • malaise
  • nasopharyngitis
  • oropharyngeal pain
50-59:
  • arthralgia
  • back pain
  • leukopenia
  • nausea
  • pain
  • alopecia
  • anaemia
  • drug ineffective
  • dyspepsia
  • fall
60+:
  • ascites
  • hepatic function abnormal
  • peritoneal tuberculosis
  • pneumonia
  • sepsis
  • drug hypersensitivity
  • dyspnoea
  • haemoptysis
  • cardiac arrest
  • left ventricular failure

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zithromax and Remicade?

Can you answer these questions?

More questions for: Zithromax, Remicade

You may be interested in these reviews

More reviews for: Zithromax, Remicade

On eHealthMe, Zithromax (azithromycin) is often used to treat bronchitis. Remicade (infliximab) is often used to treat rheumatoid arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.